Pretreatment parameters obtained from peripheral blood sample predicts invasiveness of bladder carcinoma

Urologia Internationalis

Volumn 89, Issue 4, 2012, Pages 468-472

  Can, C ^a   Baseskioglu, B ^a   Yilmaz, M ^a   Colak, E ^a   Ozen, A ^a   Yenilmez, A ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Logistic regression model; Lymphocyte; Neutrophil; Neutrophil to lymphocyte ratio; Platelets; Urothelial carcinoma

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOMA; BLOOD; CANCER INVASION; CANCER SIZE; CYSTOSCOPY; FEMALE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; THROMBOCYTE VOLUME;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84871183909     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000343278     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, et al: Cancer Incidence and Mortality Worldwide: International Agency for Research on Cancer, 2010. Available from: Http://globocan.iarc.fr
2. Jaeger N, Radeke HW, Adolphs HD, et al: Value of intravesical sonography in tumor classification of bladder carcinoma. Eur Urol 1986; 12: 76-84. (Pubitemid 16163339)
3. Sakai I, Miyake H, Harada KI, et al: Analysis of factors predicting intravesical recurrence of non-muscle invasive transitional cell carcinoma of the bladder without concomitant carcinoma in situ. Int J Urol 2006; 13: 1389-1392. (Pubitemid 44657045)
4. Prescott S, James K, Hargreave TB, et al: Intravesical Evans strain BCG therapy: Quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol 1992; 147: 1636-1642.
5. Taniguchi K, Koda S, Nishikido M, et al: Systemic immune response after intravesical instillation of bacille Calmette-Guerin (BCG) for non-muscle invasive bladder cancer. Clin Exp Immunol 1999; 115: 131-135. (Pubitemid 29030375)
6. Yamashita J, Ogawa M, Shirakusa T: Free form neutrophil elastase is an independent marker predicting recurrence in primary breast cancer. J Leukoc Biol 1995; 57: 375-378.
7. Ohno Y, Nakashima J, Ohori M, et al: Pretreatment neutrophil-to- lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol 2010; 184: 873-878.
8. Levin J, Conley CL: Thrombocytosis associated with malignant disease. Arch Intern Med 1964; 114: 497-500.
9. Sierko E, Wojtukiewicz MZ: Platelets and angiogenesis in malignancy. Semin Thromb Hemost 2004; 30: 95-108. (Pubitemid 38457304)
10. Nascimento CM, Drager BJ, Zeegers MP, et al: Epidemiology of urinary bladder cancer: From tumor development to patient's death. World J Urol 2007; 25: 285-295.
11. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
12. Madeb R, Messing EM: Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004; 22: 86-92. (Pubitemid 38479800)
13. Linn JF, Sesterhenn I, Mostofi FK, et al: The molecular characteristics of bladder cancer in young patients. J Urol 1998; 159: 1493-1496. (Pubitemid 29117327)
14. Totterman TH, Loskog A, Essand M: The immunotherapy of prostate and bladder cancer. BJU Int 2005; 96: 728-735. (Pubitemid 41391419)
15. Yamada H, Luo Y, Matsumoto T, et al: A novel expression of macrophage derived chemokine in human bladder cancer. J Urol 2005; 173: 990-995. (Pubitemid 40239382)
16. McMillan DC, Canna K, McArdle CS: Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003; 90: 215-219. (Pubitemid 36237897)
17. Walsh SR, Cook EJ, Goulder F, et al: Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-184. (Pubitemid 41254421)
18. Mantovani A, Allavena P, Sica A, et al: Cancer related inflammation. Nature 2008; 454: 436-444.
19. O'Toole C, Perlman P, Unsgaard B, et al: Cellular immunity to human urinary bladder carcinoma. Correlation to clinical stage and radiotherapy. Int J Cancer 1972; 10: 77-91.
20. Hirashima M, Higuchi S, Sakamoto K, et al: The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol 1998; 124: 329-334. (Pubitemid 28332916)
21. Lasek WA, Plodziszewska M, Gorecki D, et al: Relationship between natural killer activity and eosinophil, neutrophil and lymphocyte level in human blood. Folia Haematol 1985; 117: 907-912.
22. Kishi Y, Kopetz S, Chu YS, et al: Blood neutrophil-to lymphocyte ratio predicts survival in patients with colorectal liver metastasis treated with systemic chemotherapy. Ann Surg Oncol 2009; 16: 614-622.
23. Gomez D, Farid S, Malik HZ, et al: Preoperative neutrophil-to lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008; 32: 1757-1762.
24. Zahorec R: Ratio of neutrophil-to-lymphocyte counts. Rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5-14.
25. Nieswandt B, Hafner M, Echtenacher B, et al: Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999; 59: 1295-1300. (Pubitemid 29136261)
26. Kim YJ, Borsig L, Varki NM, et al: P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 1998; 95: 9325-9330. (Pubitemid 28506230)
27. Suppiah R, Shaheen PE, Elson P, et al: Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 2006; 107: 1793-1800. (Pubitemid 44582948)
28. Ikeda M, Furukawa H, Imamura H, et al: Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002; 9: 287-291. (Pubitemid 34298634)
29. Todenhöfer T, Renninger M, Schwentner C, et al: A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. BJU Int DOI: 10.1111/j.1464-410X.2012.11231.